Klaus Lechner

Q: What Schools Are Affiliated With Klaus Lechner

Klaus Lechner is affiliated with the following schools: Medical University of Vienna, University of Vienna

Klaus Lechner's AcademicInfluence.com Rankings

Klaus Lechner

Philosophy

#8380

Historical Rank

Logic

#3852

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Klaus Lechner's Degrees

PhD Biomedical Sciences University of Vienna
Doctorate Medicine University of Vienna

Why Is Klaus Lechner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Klaus Lechner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (2003) (3476)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. (2009) (2167)
A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII (1981) (791)
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. (2000) (606)
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. (1992) (461)
Antithrombin III deficiency and thromboembolism. (1981) (375)
How I treat autoimmune hemolytic anemias in adults. (2010) (288)
Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) (2008) (264)
1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. (2000) (249)
Hyperhomocysteinemia Is a Risk Factor of Recurrent Venous Thromboembolism (1998) (248)
A Randomized , Double-Blind , Placebo-Controlled , Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia (1997) (234)
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden (1997) (219)
Lupus Anticoagulants and Thrombosis (1985) (218)
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. (1989) (218)
Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis (2005) (217)
Interleukin-3 is a differentiation factor for human basophils. (1989) (217)
Interleukin 3 activates human blood basophils via high-affinity binding sites. (1989) (207)
Diagnostic value of immunostaining for tryptase in patients with mastocytosis. (1998) (205)
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. (2002) (196)
Diagnosis and treatment of systemic mastocytosis: state of the art (2003) (195)
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. (1995) (194)
Glycosylated hemoglobins (GHb): an index of red cell survival. (1982) (190)
Cancer-Related Microangiopathic Hemolytic Anemia: Clinical and Laboratory Features in 168 Reported Cases (2012) (181)
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening (1992) (172)
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. (1998) (171)
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. (1995) (170)
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease (1984) (157)
Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication (1994) (154)
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. (1993) (147)
Post-Partum Factor VIII Inhibitors (1995) (147)
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene (1999) (146)
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. (1994) (144)
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes (1996) (140)
Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell. (1993) (138)
Clinical significance of lupus anticoagulants in children. (1999) (135)
Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature. (2004) (135)
Acquired inhibitors in nonhemophilic patients. (1974) (134)
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. (2001) (134)
Acquired factor V inhibitors. (1998) (131)
Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant (1983) (126)
The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group. (1980) (122)
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. (2001) (120)
IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. (1991) (120)
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia (1997) (120)
Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden (1999) (118)
Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia. (1998) (117)
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. (2007) (113)
Studies on the Neutralizing Effects of Protamine on Unfractionated and Low Molecular Weight Heparin (Fragmin®) at the Site of Activation of the Coagulation System in Man (1995) (112)
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. (1997) (111)
The Risk of Thromboembolism in Asymptomatic Patients with Protein C and Protein S Deficiency: A Prospective Cohort Study (1994) (111)
Interleukin 4 promotes expression of mast cell ICAM-1 antigen. (1991) (110)
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis (2002) (109)
The postoperative splenic/portal vein thrombosis after splenectomy and its prevention – an unresolved issue (2008) (107)
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. (2005) (106)
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review (2008) (106)
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. (1980) (106)
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia (1997) (105)
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). (2001) (104)
Probability of Recurrence of Thrombosis in Patients with and without Factor V Leiden (1996) (104)
Clinical and Biologic Diversity of Leukemias Occurring in Patients with Mastocytosis (2000) (103)
Impaired Fibrinolytic Capacity Predisposes for Recurrence of Venous Thrombosis (1984) (103)
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. (1994) (101)
Failure to detect IL-3-binding sites on human mast cells. (1990) (100)
D-Dimer and TAT Measurement in Patients with Deep Venous Thrombosis: Utility in Diagnosis and Judgement of Anticoagulant Treatment Effectiveness (1990) (99)
Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. (1987) (98)
The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. (1997) (96)
Protein C Deficiency in Two Austrian Families (1983) (95)
Prevention of Arterial and Pulmonary Embolism by Oral Anticoagulants in Patients with Dilated Cardiomyopathy (1985) (95)
Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: Comparison with albumin (1994) (95)
P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. (1994) (95)
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. (1999) (95)
Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates--synergism with recombinant human granulocyte/macrophage colony-stimulating factor. (1990) (93)
Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo (1979) (93)
The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. (2006) (93)
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. (1990) (93)
Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia (1985) (91)
Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16). (2002) (90)
Autoimmune thrombocytopenia in non-Hodgkin’s lymphomas (2008) (89)
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer. (1990) (88)
Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas (2007) (86)
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia (2002) (86)
Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentrates (1987) (85)
The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. (2002) (85)
Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome. (1997) (85)
Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. (1998) (84)
Homozygous Antithrombin Deficiency Type II (99 Leu to Phe Mutation) and Childhood Thromboembolism (2001) (84)
The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. (2002) (83)
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study. (1997) (80)
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation (2002) (80)
Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia (1998) (80)
Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells* (1997) (79)
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia (1999) (79)
Coagulation abnormalities in liver disease. (2008) (79)
Rituximab for the treatment of acquired antibodies to factor VIII. (2007) (77)
A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. (1997) (75)
Severe immune hemolysis after minor ABO‐mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning (2002) (75)
ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation (2003) (74)
Human blood basophils display a unique phenotype including activation linked membrane structures. (1987) (74)
Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes (2002) (72)
Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism (2001) (72)
Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens. (1993) (72)
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates. (1992) (71)
Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. (1999) (71)
Interleukin 10 inhibits growth and granulocyte/macrophage colony- stimulating factor production in chronic myelomonocytic leukemia cells (1996) (70)
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. (2000) (70)
ORAL CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR V LEIDEN (1996) (70)
Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature (2010) (68)
Elimination of Acquired Factor VIII Antibodies by Extracorporal Antibody-based Immunoadsorption (Ig-Therasorb®) (1995) (68)
Tumor necrosis factor α and interleukin-1β mRNA expression in HMC-1 cells : differential regulation of gene product expression by recombinant interleukin-4 (1993) (66)
Paraneoplastic autoimmune thrombocytopenia in solid tumors. (2012) (64)
Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. (1985) (64)
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors (2005) (63)
Antithrombin III Concentrates-Are they Clinically Useful? (1995) (62)
Solid Tumors and Factor VIII Antibodies (1999) (62)
Drug resistance factors in acute myeloid leukemia: a comparative analysis (2000) (62)
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study. (1998) (62)
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center study (1996) (62)
Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release. (1997) (62)
Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. (1988) (61)
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia (1996) (60)
Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. (1993) (60)
Quantification of minimal residual disease in patients with BCR‐ABL‐positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction (1999) (60)
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis. (2001) (60)
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. (1993) (59)
Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. (1995) (59)
A New Type of Coagulation Inhibitor (1969) (59)
New Aspects in Thrombosis Research: Possible Role of Mast Cells as Profibrinolytic and Antithrombotic Cells (2002) (59)
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse (2004) (56)
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. (1990) (56)
Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms. (2001) (56)
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg"). (1990) (55)
The surface membrane antigen phenotype of human blood basophils (1994) (54)
Purification of human basophils and mast cells by multistep separation technique and mAb to CDw17 and CD117/c-kit. (1995) (54)
SUCCESSFUL LUNG TRANSPLANTATION FOR BRONCHIOLITIS OBLITERANS AFTER ALLOGENEIC MARROW TRANSPLANTATION (2001) (53)
Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. (2000) (51)
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. (1990) (51)
Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3. (1996) (51)
Immunoblot analysis shows changes in factor VIII inhibitor chain specificity in factor VIII inhibitor patients over time. (1988) (50)
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. (2002) (50)
Colony growth characteristics in chronic myelomonocytic leukemia. (1988) (50)
Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma (2010) (50)
A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. (1996) (50)
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26) (2000) (49)
Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells. (2001) (49)
MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT‐VERSUS-HOST DISEASE PROPHYLAXIS (1995) (49)
Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies. (1990) (49)
Thrombocytopenia associated with low-molecular-weight heparin (1991) (49)
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia (1996) (49)
Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein. (1993) (49)
Type beta transforming growth factors promote interleukin-3 (IL-3)-dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils. (1992) (48)
Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. (1994) (48)
Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome (2000) (47)
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome (2004) (47)
Homocysteine levels in polycythaemia vera and essential thrombocythaemia (1999) (47)
Plasmapheresis: its value in the management of patients with antibodies to factor VIII. (1982) (47)
Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. (1991) (47)
Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells. (1996) (46)
Oral cyclosporin‐A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure * (1989) (46)
T-Cell Alterations in Hemophiliacs Treated with Commercial Clotting Factor Concentrates (1983) (46)
Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR (1999) (44)
Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. (1989) (44)
PCR‐monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR‐ABL‐positive acute lymphoblastic leukaemia (1995) (44)
Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques. (1999) (44)
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis. (1999) (44)
Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21. (2001) (43)
What Have Mast Cells To Do with Edema Formation, the Consecutive Repair and Fibrinolysis? (1997) (43)
Increased angiogenesis in the bone marrow of patients with systemic mastocytosis. (2002) (43)
IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites. (1990) (42)
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes. (2001) (42)
Multidrug resistance in leukemias and its reversal. (1996) (41)
A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val. (2001) (40)
The Prevalence of Hereditary Antithrombin-III Deficiency in Patients with a History of Venous Thromboembolism (1985) (40)
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category. (2003) (40)
Post-transplant acute myeloid leukemia (PT-AML) (1999) (39)
PML‐RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months (1994) (39)
Evidence for an Increased Generation of Prostacyclin in the Microvasculature and an Impairment of the Platelet α-Granule Release in Chronic Renal Failure (1988) (39)
Stem cell factor-induced downregulation of c-kit in human lung mast cells and HMC-1 mast cells. (1996) (39)
Factors affecting long‐term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry (2002) (39)
High Levels of Plasma Protein C in Nephrotic Syndrome (1985) (37)
Recombinant human erythropoietin activates a broad spectrum of progenitor cells. (1990) (37)
Monitoring of minimal residual disease in patients with MLL–AF6‐positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction (2000) (37)
Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. (1996) (37)
Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic Leukemia (2001) (36)
Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML (1998) (36)
Phenotypic and functional characterization of mast cells derived from renal tumor tissues. (1998) (35)
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia. (1999) (35)
Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. (1993) (35)
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL) (2004) (35)
Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection (1993) (35)
Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti‐PIA1 specificity: evidence for a host‐derived immune reaction (1989) (35)
Early detection of hematopoietic engraftment after bone marrow and peripheral blood stem cell transplantation by highly fluorescent reticulocyte counts. (1994) (34)
MRP Expression in Acute Myeloid Leukemia (1999) (34)
A Comparison of the Bethesda and New Oxford Methods of Factor VIII Antibody Assay (1982) (34)
The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera (1999) (34)
High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study. (2000) (33)
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors (1998) (33)
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. (2002) (33)
Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden. (1998) (33)
Levels of Prothrombin Fragment F1+2 in Patients with Hyperhomocysteinemia and a History of Venous Thromboembolism (1997) (33)
Bone Marrow Microvessel Density and it's Prognostic Significance in AML (2004) (33)
Activation of Human Mast Cells through Stem Cell Factor Receptor (KIT) Is Associated with Expression of bcl-2 (2002) (32)
Inflammation in patients with lupus anticoagulant and implications for thrombosis. (2005) (32)
Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells (1991) (32)
Transient Lupus Anticoagulants in Children: Stepwise Disappearance of Diagnostic Features (2000) (32)
Interleukin-10 inhibits burst-forming unit-erythroid growth by suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells. (1999) (32)
Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. (2001) (32)
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene. (1999) (32)
A case of bone marrow mastocytosis associated with multiple myeloma (1998) (32)
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF. (1990) (31)
Fludarabine therapy in Waldenström's macroglobulinemia (2000) (31)
Functional asplenia after bone marrow transplantation. (1990) (31)
Prothrombin Fragment F1+2 Is not Predictive for Recurrent Venous Thromboembolism (1997) (31)
Thrombin Augments Vascular Cell-dependent Migration of Human Mast Cells: Role of MGF (1997) (31)
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems (2001) (31)
Differential expression of cell surface integrins on human mast cells and human basophils (1992) (30)
Activation of Factor X (1965) (30)
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose‐escalating infusion of donor leucocytes (1997) (30)
Immunophenotypic and functional characterization of human tonsillar mast cells (1997) (29)
Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support (1998) (29)
Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006 (2009) (29)
Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia (2003) (29)
Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin). (1995) (29)
Recombinant human erythropoietin and hematopoietic progenitor cells in vivo [letter] (1989) (28)
Anticardiolipin Antibodies Are Elevated in HIV-1 Infected Haemophiliacs but Do Not Predict for Disease Progression (1989) (28)
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells (1999) (28)
Risk of recurrence after a first venous thromboembolic event in young women (2007) (28)
Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia (1999) (28)
HLA-DR and Factor VIII Antibodies in Hemophilia A (1984) (27)
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. (1993) (27)
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma (2001) (27)
Inhibition rather than Enhancement of Hemostatic System Activation during Initiation of Oral Anticoagulant Treatment (1997) (26)
Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. (1992) (26)
Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia (2000) (26)
Familial lupus anticoagulant: a case report and review of the literature. (1998) (25)
HAEMOLYTIC TRANSFUSION REACTIONS DUE TO HLA ANTIBODIES A Prospective Study Combining Red-cell Serology with Investigations of Chromium-51-labelled Red-cell Kinetics (1987) (25)
Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens. (1985) (25)
Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype. (1999) (24)
Rapid elimination of a high-titer spontaneous factor V antibody by extracorporeal antibody-based immunoadsorption and immunosuppression (1995) (24)
Anticardiolipin antibodies in patients with venous thrombosis. (1991) (24)
Effect of Treatment with Activated Prothrombin Complex Concentrate (FEIBA) on Factor VIII-Antibody Level (1978) (24)
A Novel Effective and Safe Consolidation for Patients Over 60 Years with Acute Myeloid Leukemia (2004) (23)
Interleukin-10 Inhibits Erythropoietin-Independent Growth of Erythroid Bursts in Patients With Polycythemia Vera (1998) (23)
Glycosylated hemoglobin as a long-term parameter in appraising the severity of hemolytic disease (1983) (23)
Effects of a Low Molecular Weight Heparin (Fragmin®) and of Unfractionated Heparin on Coagulation Activation at the Site of Plug Formation In Vivo (1994) (23)
Coincidence of severe aplastic anaemia with multiple sclerosis or thyroid disorders. Report of 5 cases. (1994) (23)
IIB von Willebrand's disease: pathogenetic and therapeutic studies (1988) (23)
High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival (2003) (22)
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants (2001) (22)
Blood coagulation changes under L-asparaginase therapy. (1970) (22)
Clopidogrel and aplastic anaemia (2001) (22)
Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagulation, fibrinolysis and unspecific proteolysis (1990) (22)
Stem Cell Factor-induced Bone Marrow Mast Cell Hyperplasia Mimicking Systemic Mastocytosis (SM): Histopathologic and Morphologic Evaluation with Special Reference to Recently Established SM-criteria (2002) (22)
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. (1997) (22)
Effect of interleukin-3 on responsiveness to granulocyte-colony-stimulating factor in severe aplastic anemia. (1992) (21)
Differential response of human basophils and mast cells to recombinant chemokines (1995) (21)
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis (1998) (21)
Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia. (2003) (20)
Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status (1997) (20)
Myeloid progenitor cells in the peripheral blood of patients with hairy cell leukemia and other "leukemic" lymphoproliferative disorders. (1986) (20)
Acquired immune-mediated thrombophilia in lymphoproliferative disorders (2011) (20)
Management of adult immune thrombocytopenia. (2001) (20)
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience. (2011) (20)
Human basophils express interleukin-4 receptors (1990) (20)
INCREASED RATIO OF GRANULOCYTE/MACROPHAGE PROGENITOR CELLS (CFU‐GM) TO MULTILINEAGE PROGENITOR CELLS (CFU‐mix) IN THE PERIPHERAL BLOOD FROM PATIENTS WITH ACUTE NON‐LYMPHOBLASTIC LEUKAEMIA IN VERY EARLY REMISSION (1986) (20)
Risk of recurrence after a first venous thromboembolic event in young women. (2007) (19)
Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia. (2002) (19)
PLASMA D-DIMER AND PULMONARY EMBOLISM (1989) (19)
Successful re‐treatment of an anti‐interferon resistant polycythaemia vera patient with lymphoblastoid interferon‐αN1 and in vitro studies on the specificity of the antibodies (1994) (19)
Peripheral nerve lesions in haemophilia (2004) (19)
1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor. (1990) (18)
A New Approach in the Treatment of Peripheral Arterial Occlusions: Defibrination With Arvin (1974) (18)
CRM+ severe Fletcher factor deficiency associated with Graves' disease. (1984) (18)
Effect of interleukin‐3 pretreatment on granulocyte/macrophage colony‐stimulating factor induced mobilization of circulating haemopoietic progenitor cells (1995) (18)
Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings (2014) (17)
Thromboxane A2 and Prostacyclin Generation in the Microvasculature of Patients with Atherosclerosis – Effect of Low-Dose Aspirin (1989) (17)
HLA antigens in immunologic thrombocytopenic purpura (ITP). (2009) (17)
MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update. (1993) (17)
Diagnosis of Protein C Deficiency in Patients on Oral Anticoagulant Treatment: Comparison of Three Different Functional Protein C Assays (1990) (17)
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience. (2005) (17)
Recurrent, Isolated Factor X Deficiency in Myeloma: Repeated Normalization of Factor X Levels after Cytostatic Chemotherapy Followed by Late Treatment Failure Associated with the Development of Systemic Amyloidosis (1992) (17)
Circulating committed and pluripotent haemopoietic progenitor cells, in infants. (1986) (17)
Translocation (16;21)(p11;q22) in acute monoblastic leukemia with erythrophagocytosis. (1991) (17)
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia. (1999) (17)
Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisolone. (2009) (17)
Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia (1998) (16)
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma (2001) (16)
Quantitation of Minimal Residual Disease in Acute Myeloid Leukemia by Tryptase Monitoring Identifies a Group of Patients with a High Risk of Relapse (2005) (16)
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis. (1998) (16)
MDR1 RNA expression is an independent prognostic factor in acute myeloid leukemia. (1992) (16)
Low Dose Thalidomide in Patients with Relapsed or Refractory Multiple Myeloma (2003) (16)
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma. (2014) (16)
HTLV-I Antibody Status in Hemophilia Patients Treated with Factor Concentrates Prepared from U.S. Plasma Sources and in Hemophilia Patients with AIDS (1985) (16)
Clonal T cell‐mediated cyclic thrombocytopenia (2002) (16)
A Hitherto not Described Enzyme Defect in Thrombasthenia: Glutathionreductase Deficiency (1968) (15)
Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. (1989) (15)
Factor VIII inhibitor in a patient with mild hemophilia A. (1972) (15)
Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene (1991) (15)
[Vitamin B12 deficiency. New data on an old theme]. (2005) (15)
[Antithrombin III deficiency and tendency to thrombosis (author's transl)]. (1977) (15)
MRP expression in acute myeloid leukemia. An update. (1999) (15)
Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments. (1993) (15)
Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3c in chronic idiopathic autoimmune thrombocytopenia: relation to the sequestration pattern of 111indium labelled platelets. (2009) (15)
Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia (1992) (15)
Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis. (1997) (15)
Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients [letter; comment] (1992) (14)
Ineffectiveness of interferon-γ in the treatment of idiopathic myelofibrosis: a pilot study (2001) (14)
Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: Case report and review of the literature (1992) (14)
Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia (1995) (14)
Effects of interferon-α2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis (2000) (14)
Prospective Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia with Inversion(16) by CBFβ/MYH11 RT-PCR: Implications for a Monitoring Schedule and for Treatment Decisions (2001) (14)
Impaired Fibrinolytic Response To DDAVP And Venous Occlusion In A Subgroup Of Patients With Von Willebrand’s Disease (1981) (14)
[Thrombolytic therapy in acute arterial occlusions]. (1970) (14)
Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes (2001) (13)
Clearance of PCR‐detectable lymphoma cells from the peripheral blood, but not bone marrow after therapy with campath‐1H (1995) (13)
Amplification of ribosomal RNA genes in acute myeloid leukemia (2001) (13)
Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 or FAB M4Eo subtype (1994) (13)
[Problems of long-term therapy with anticoagulants]. (1992) (13)
Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes (1988) (13)
Primary hodgkin's disease of the lung (1983) (13)
Aplastic anemia: assessment of myeloid progenitor cells in the bone marrow and blood provides prognostic information. (1985) (13)
Low-molecular-weight heparin-induced skin necrosis (1998) (13)
Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia (1994) (13)
Subdural hygromas after bone marrow transplantation: results of a prospective study. (1998) (13)
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia. (1998) (13)
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion (1996) (13)
Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL) (1993) (13)
Autoantibody Reactivity in a Case of Schnitzler’s Syndrome: Evidence for a Th1-Like Response and Detection of IgG2 Anti-FcεRIα Antibodies (2000) (13)
IL‐10 increases the number of CFU–GM generatedby ex vivo expansion of unmanipulated human MNCsand selected CD34+ cells (2001) (13)
Unexpected absence of a myeloid surface antigen (3-fucosyl-N-acetyllactosamine) in promyelocytic leukemia. (1985) (13)
Hepatic and splenic abscesses — a common complication of intensive chemotherapy of acute myeloid leukemia (AML) (1991) (12)
LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR IN PATIENTS WITH ANGINA PECTORIS (1987) (12)
Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones. (2003) (12)
Studies on Tissue Thromboplastin II. Species Specificity*) (1965) (12)
Immune-Mediated Disorders Causing Bleeding or Thrombosis in Lymphoproliferative Diseases (2014) (12)
Immunophenotypic characterization of human bone marrow endosteal cells. (1999) (12)
Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera. (1998) (12)
Late spontaneous remissions in severe adult autoimmune thrombocytopenia (2007) (12)
Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? (2003) (12)
[Inactive factor VIII in hemophilia A and Willebrand's disease]. (1972) (12)
Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain‐Barré, and a unique chromosome abnormality (1984) (11)
Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes (2003) (11)
Prognosis of patients with a second relapse of acute myeloid leukemia (2000) (11)
Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature (1999) (11)
In vitro culture studies of granulocyte/macrophage and erythroid progenitor cells in lymphoproliferative disorders (1986) (11)
Ex vivo expansion of long‐term culture initiating marrow cells by IL‐10, SCF, and IL‐3 (2002) (11)
Cytogenetic risk groups in acute myeloblastic leukaemia differ greatly in their semi‐solid colony growth (2001) (11)
Lupus anticoagulant and clinical correlates (1992) (11)
Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia (2016) (11)
Postoperative paraneoplastic factor VIII auto‐antibodies in patients with solid tumours (2011) (11)
Treatment of severe chronic idiopathic thrombocytopenic purpura in adults with high-dose intravenous gammaglobulin. (2009) (10)
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans. (1994) (10)
Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature (1999) (10)
Posttransfusion purpura (1986) (10)
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiency (1997) (10)
Autoimmune‐thrombocytopenia and sle in a patient with 5q‐anomaly and deletion of the c‐fms oncogene (1994) (10)
Effect of ritanserin, a 5‐hydroxytryptamine2– receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo (1990) (10)
Factor IX-Inhibitors (1971) (10)
Sonography: a method for localization of hematomas in hemophiliacs. (1976) (10)
HLA-DR in chronic idiopathic thrombocytopenic purpura (ITP). (1981) (10)
Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free Medium (2000) (10)
Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia. (2003) (9)
Vitamin B12 deficiency: New data on an old disease (2005) (9)
Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF) (1993) (9)
Human basophils express interleukin-4 receptors. (1990) (9)
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation (1999) (9)
Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. (1992) (9)
Gamma-interferon in myelodysplastic syndromes: a pilot study. (1990) (8)
Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia (1997) (8)
Range and clinical significance of the number of myeloid-committed stem cells in the blood of patients with acute leukaemia in remission. (1984) (8)
PROTEIN S AND ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH LUPUS ANTICOAGULANT WITH OR WITHOUT THROMBOSIS (1987) (8)
Is it possible to catch leukemia from a cat? (1995) (8)
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation (2001) (8)
Recombinant human erythropoietin: a multipotential hemopoietic growth factor in vivo and in vitro. (1990) (8)
High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL) — a single-institution study (1994) (8)
Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves. (1981) (8)
Cytogenetic studies in bone marrow transplant recipients (1986) (8)
MDRl gene expression in acute myeloid leukemia (1993) (8)
Type beta transforming growth factors promote interleukin-3 (IL-3)- dependent differentiation of human basophils but inhibit IL-3-dependent differentiation of human eosinophils (1992) (8)
Massive postoperative intramuscular bleeding in acquired von Willebrand's disease (2002) (8)
Detection of Trisomy 8 in Donor-Derived Ph− Cells in a Patient with Ph+ Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation (2004) (7)
Thromboembolism in patients with prosthetic heart valves. An adequately controlled intense anticoagulant therapy and its influence on the occurrence of thromboembolism in relation to valve type. (1986) (7)
[The effect of chlorpromazine on catecholamine and 5-hydroxytryptamine metabolism in the rat brain]. (1960) (7)
Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia (1999) (7)
Rapid neonatal diagnosis of type IIB von Willebrand disease using the polymerase chain reaction. (1991) (7)
Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplantation (1989) (7)
Disseminated intravascular coagulation and decrease in fibrinogen levels induced by vincristine/prednisolone therapy of lymphoid blast crisis of chronic myeloid leukemia (1991) (7)
Factor X Vorarlberg, a New Variant of Hereditary Factor X DeficiencyX (1979) (7)
Azidothymidine (AZT) in the Treatment of Symptomatic HIV-1-Infected Hemophiliacs (1990) (7)
Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis (1996) (7)
Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype. (2004) (7)
Platelet and endothelial cell function in patients with insulin-dependent diabetes mellitus with excellent, good, or poor metabolic control. (1996) (7)
Allogeneic BMT for Chronic Myelocytic Leukaemia (CML): Some Ph+ Bone Marrow Cells May Resist Cyclophosphamide and TBI Conditioning but are Gradually Deleted during Donor-Type Haemopoietic Reconstitution (1985) (6)
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts. (1992) (6)
Protein C- and coagulation factor levels during the initial phase of oral anticoagulant therapy (low dose regimen) in a patient with heterozygous protein C deficiency. (1987) (6)
Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study. (2001) (6)
Pure red cell aplasia in a case of Ph negative BCR/ABL rearranged CML with t(12;14)(q23;p11). (1991) (6)
Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. (1995) (6)
Indium 111‐labeled platelet kinetic studies and platelet‐ associated igg in hairy cell leukemia (1986) (6)
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia (1991) (6)
Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report (1994) (6)
Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment (1999) (6)
Effect of interleukin-3, stem cell factor and granulocyte–macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture (2000) (6)
G-CSF stimulation of donor myelopoiesis prolongs survival of relapsed BCR-ABL-positive acute lymphoblastic leukemia after allogeneic marrow transplantation. (1996) (5)
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia (1996) (5)
Dexverapamil as resistance modifier in acute myeloid leukaemia (2006) (5)
Pacing‐induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulation (1991) (5)
Coumarin induced acral skin necrosis associated with hereditary protein C deficiency (1986) (5)
Immune Reactive Factor IX in Acquired Factor IX Deficiency (1972) (5)
Isolation and Characterization of Blood Clotting Factors VII and X (1968) (5)
SUBDURAL HYGROMAS AFTER BONE MARROW TRANSPLANTATION (1998) (5)
Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment (2016) (5)
Hemophilia and thrombocytopenia in a patient with impaired cellular immunity (1984) (5)
High Risk of Acquired Immune Deficiency Syndrome (AIDS) and of AIDS Related Complex (ARC) in Hemophiliacs Seropositive for more than 5 Years (1989) (5)
MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome. (1994) (5)
Treatment of acute leukemia. (1999) (5)
Molecular Disease Eradication is a Prerequisite for Long-term Remission in Patients with t(8;21) Positive Acute Myeloid Leukemia: a Single Center Study (2004) (5)
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia (1998) (5)
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy. (1993) (5)
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia (2000) (5)
Mobilization of circulating hemopoietic progenitor cells by rhIL‐3 and rhGM‐CSF in primates (1992) (4)
Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients. (1988) (4)
THROMBOSIS Inhibition of prostacyclin and thromboxane A 2 generation by low-dose aspirin at the site of plug formation in man in vivo (2005) (4)
Autoantibody reactivity in a case of Schnitzler's syndrome: evidence for a Th1-like response and detection of IgG2 anti-FcepsilonRIalpha antibodies. (2000) (4)
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia (2014) (4)
Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia (1993) (4)
Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation (2003) (4)
Symmetrical necrosis of globus pallidus with severe gait disturbance in a patient with myelodysplastic syndrome given allogeneic marrow transplantation (1997) (4)
Complement receptor expression on basophils and mast cells: Evidence for mast cell heterogeneity (1994) (4)
RANDOMIZED TRIAL OF ANTITHROMBIN III VERSUS PLACEBO IN PATIENTS UNDERGOING PERITONEO-VENOUS SHUNT OPERATION (1987) (4)
Immunoreactive Factor VIII in Carriers of Hemophilia A+ and A- (1973) (4)
Megakaryocytopoiesis Stimulating Factors are Highly Increased in Sera from Patients After Bone Marrow Transplantation (1985) (4)
Post-transfusion thrombocytopenic purpura: Immunological and clinical studies in two cases and review of the literature (1980) (4)
[Oral anticoagulant therapy--renaissance of an old therapy?]. (1987) (4)
[Substitution therapy using antithrombin III concentrate]. (2008) (3)
[Deficiency anemias in tropical countries]. (1984) (3)
Relationship between MDR1 gene and surface markers in acute myeloid leukemia. (1997) (3)
Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemia. (1999) (3)
[Intracranial and spinal hemorrhage in haemophilia (author's transl)]. (1976) (3)
Circulating Stem Cells in Patients with Akute Leukaemia in Remission (1985) (3)
[Gangrene following erroneous intra-arterial injection of dicloxacillin]. (1971) (3)
Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better? (1992) (3)
Acquired Deficiency of Fibrinogen (Fbg) and Factor VII (F VII) During and Following Immunosuppression for Severe Aplastic Anemia (SAA) with Antithymocyte Globulin (ATG) and High-Dose Methylprednisolone (MP) (1985) (3)
Relation of In Vitro Growth Characteristics to Cytogenetics and Treatment Outcome in Acute Myeloid Leukemia: Prognostic Significance in Patients with a Normal Karyotype (2003) (3)
Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome. (1999) (3)
Why clinicians should be interested in Interleukin-3 (1990) (3)
Immunoreactive inhibin in human follicular fluid in an ovarian hyperstimulation programme for in vitro fertilization: correlations and different forms. (1993) (3)
Survival and quality of life in 23 patients with severe aplastic anemia treated with bone marrow transplantation (BMT) (1987) (2)
[Blood coagulation disorders in paraproteinemic hemoblastoses]. (1972) (2)
[Home treatment in hemophilia]. (1987) (2)
[Splenectomy in idiopathic thrombocytopenic purpura: short- and long-term results (author's transl)]. (1978) (2)
Increased risk of thrombosis due to abnormalities of the hemostatic system. (1986) (2)
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies. (1998) (2)
[Bronchiolitis obliterans organizing pneumonia with acute respiratory insufficiency]. (2008) (2)
Pregnancy and delivery after bone marrow transplantation (BMT) for severe aplastic anemia (SAA). A case report. (1987) (2)
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning (2002) (2)
Interleukin 10 Inhibits Growth and Granulocyte/Macr ophage Colony-stimulati ng Factor Production in Chronic Myelomonocytic Leukemia Cells By Klaus Geissler,* Leopold Ohler,* Manuela F6dinger,~ (1996) (2)
Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL. (2000) (2)
[Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders]. (1972) (2)
[Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases]. (1996) (2)
[The importance of plasma- pheresis during intensive postoperative care in hemophilia]. (1968) (2)
Interleukin‐10 inhibits autonomous myelopoiesis in patients with myelofibrosis (2015) (2)
Inhibitor development in two patients with mild haemophilia A – spontaneous disappearance and no recurrence of the inhibitor after re-challenge (2012) (2)
Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo (1992) (2)
PERIPHERAL BLOOD PLURIPOTENT PROGENITOR CELLS IN ACUTE LYMPHOBLASTIC LEUKAEMIA BEFORE, DURING AND AFTER CHEMOTHERAPY (1988) (2)
Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with both myeloproliferative and dysplastic features. (2000) (2)
Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia (1995) (2)
Inactive factor VIII in hemophilia A and Willebrand's disease. A study of 117 cases. (1972) (2)
[A simple method for the preparation of human factor VII-deficient plasma]. (1967) (2)
RADIOIMMUNOLOGICAL DETERMINATION OF SERUM NEOPTERIN IN PATIENTS FOLLOWING BONE MARROW TRANSPLANTATION - FIRST RESULTS (1985) (1)
[Advances in the treatment of chronic lymphocytic leukemia (CLL)]. (1998) (1)
T cell receptor alpha mRNA transcription in T-lymphoblastic transformation of chronic myelocytic leukemia. (1988) (1)
Bone Marrow Transplantation (BMT) for Severe Aplastic Anemia (SAA): Results Obtained in 19 Patients (1985) (1)
Highly refractory acute myeloid leukemia (2004) (1)
R-metHuG-CSF Combined with Chemotherapy for Treatment of Adult ALL — Pilot Study (1994) (1)
Acute Monoblastic Leukemia with Erythrophagocytosis (1991) (1)
The Action of an Aniline Derivative (AN 162) on Blood Coagulation and on Platelets (1971) (1)
[Effector cells in allergy: biological principles and new pharmacologic concepts]. (1993) (1)
Erroneously low APC ratio in patients with lupus anticoagulant (1995) (1)
Prolonged Third Remission in a Patient With Acute Promyelocytic Leukemia After Consolidation Chemotherapy With Intermittent Intermediate Dose Ara-C and Maintenance With Intermittent all-trans Retinoic Acid (ATRA) (2000) (1)
Systemic candidiasis complicating bone marrow transplantation in aplastic anemia. Case report. (1982) (1)
MINI-REVIEW AND REPORT OF THREE CASES Post-transplant acute myeloid leukemia (PT-AML) (1999) (1)
[Polycythaemia vera--diagnosis and therapy]. (1999) (1)
Pregnancy and delivery after bone marrow transplantation (BMT) for severe aplastic anemia (SAA) (1987) (1)
Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia. (2003) (1)
[Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma]. (1993) (1)
The action of methylene blue on monoamine oxidase and the catecholamines and the metabolism of 5-hydroxytryptamine in brain (1961) (1)
T-Cell Subsets in Female Sexual Partners of Asymptomatic Hemophiliacs (1984) (1)
[The disseminated intravascular coagulation. Diagnosis and therapy on a medical intensive care unit (author's transl)]. (1977) (1)
[Chronic lymphatic leukemia]. (1994) (1)
[Therapy of severe aplastic anemia (SAA) by bone marrow transplantation (BMT) or immunosuppression?]. (1987) (1)
[Adult autoimmune thrombocytopenia: diagnosis and treatment]. (2006) (1)
[Antithrombin III deficiency: an important risk factor for venous thromboembolism]. (2008) (1)
In Vivo Synergism of Interleukin-3 and Interleukin-6 on Thrombopoiesis in Primates (1992) (1)
Protein C Determination in Patients with Thrombotic Disease and Disseminated Intravascular Coagulation (1985) (1)
Fibrinolysis Plasminogen Activator Expression and The Mast Cell as Site of Tissue-Type (1998) (1)
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). (1999) (1)
[The effect of methylene blue on monoamine oxidase and the catechol amine and 5-hydroxytryptamine metabolism of the brain]. (1961) (1)
228 Natural history of impaired fibrinolytic response in patients with a history of deep venous thrombosis (1988) (1)
HEAT INACTIVATED HIGHLY PURIFIED FACTOR VIII CONCENTRATE IN THE TREATMENT OF HEMOPHILIACS (1987) (1)
[Blood coagulation disorders following heart surgery with the aid of extracorporeal circulation]. (1967) (1)
[Certain and uncertain aspects in the diagnosis of thrombophilia]. (1983) (1)
Matched unrelated donor marrow transplantation in patients with advanced acute leukemia. (1998) (1)
[Osler's disease]. (1968) (1)
[50 years GTH -- expectations, progress, disappointments. A personal perspective]. (2006) (1)
On the purification factor VII from bovine plasma. (1966) (1)
Circulating myeloid progenitor cells in patients with aml after induction chemotherapy (1986) (1)
[Etiology, clinical significance and therapy of antithrombin III deficiencies]. (1983) (0)
[Blood coagulation problems in cardiologic intensive care]. (1983) (0)
High dose ara c and amsacrine for the treatment of refractory and recurrent acute myeloid leukemia aml (1987) (0)
Differential expression of complement (C−) AGs on human basophils, skin mast cells and other mast cell subsets (1994) (0)
Expression of the MDR1 Gene and Treatment Outcome in Acute Nonlymphocytic Leukemia (1992) (0)
[Coagulation disorders in acute liver failure and their substitution]. (1979) (0)
Annual congress of the Austrian Society of Hematology and Oncology and the Hungarian Societies of Hematology and Oncology. Graz, 27-30 September 1992. Abstracts. (1992) (0)
RISK FACTORS FOR AIDS AND ARC IN MULTITRANSHJSED HAEMOPHILIACS: ASSOCIATION OF A WEAK GAG P 18 IN WESTERN BLOT (WB) AND IMMUNE THROMBOCYTOPENIA? (1987) (0)
[Supportive therapy with thrombocyte concentrates in patients with acute leukemia]. (1987) (0)
Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen. (1991) (0)
Mast cell increase and redistribution in auricular thrombosis (1994) (0)
[A 20-year-old woman with persistent fever and sonographically demonstrated foci in the spleen]. (1984) (0)
[Use of genetic technics in medical diagnosis exemplified by hemophilia A]. (1987) (0)
[A 61-year-old patient with recurrent abdominal pain and palpable tumor in the left epigastrium]. (1983) (0)
[Protein C deficiency and thrombosis diathesis]. (1984) (0)
Mono clonal antibodies as a diagnostic tool in inherited disorders of platelet function (1983) (0)
The Spectrum of Cutaneous Graft Versus Host Disease (1985) (0)
[A 62-year-old patient with recurring venous thromboses of the leg and lung infarcts despite therapy with oral anticoagulants]. (1986) (0)
COAGULATION ACTIVATION AND OCCURRENCE OF HYPOFIBRINOGENEMIA IN PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA (1987) (0)
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience. (2000) (0)
[Blood coagulation and fibrinolysis in women receiving estrogen gestagen and estrogen-gestagen-contraceptives] (1976) (0)
[Therapy of acute leukemia in adults]. (1991) (0)
[Disseminated intravascular coagulation: diagnosis and treatment on a medical intensive care unit (proceedings)]. (1976) (0)
[Inhibitor of prothrombin activation]. (1969) (0)
[Amaurosis fungax. Studies on hemodynamics and platelet function]. (1980) (0)
80 Phenotypic analysis of endosteal cells in myelodysplastic syndromes and other hemopoietic disorders (1997) (0)
[New viewpoints in the therapy of hemophilia (proceedings)]. (1976) (0)
IS IS POSSIBLE TO CATCH LEUKAEMIA FORM A CAT (1995) (0)
No evidence for an effect of disparities of polymorphic cytokine genes and selected minor antigens on GVHD and survival in a Viennese patient group undergoing bone marrow transplantation (2002) (0)
IL-4 RECEPTOR ON BASOPHILS 1735 Histamine release from CGL basophils (2003) (0)
[Internal medical problems in hemorrhagic diathesis following surgery]. (1965) (0)
Dmg treatment is superior to allografting as first-line therapy in chronic myeloid leukemia. Commentary (2007) (0)
Generation ofLeukemia-Derived Dendritic Cells from Patients withAML (2001) (0)
[Therapeutic defibrination with ancrod (author's transl)]. (1973) (0)
Phenotyping of human basophils and mast cells (1994) (0)
Annual congress of the austrian and German societies of hematology and oncology ulm, October 7th–10th, 1984 abstracts (2004) (0)
Results Hodgkin lymphoma associated with autoimmune hemolytic anemia (2010) (0)
On the source of autoprothrombin C. (1965) (0)
[A 32-year-old patient with fever, bone pain and a tumor in the region of the lumbar spine]. (1983) (0)
Deficiency of the Autologous Mixed Lymphocyte Reaction in Patients with Classic Hemophilia Treated with Commercial Factor Vil Concentrate (2013) (0)
[Summary of work session 1: Blood coagulation in gastroenterology]. (1976) (0)
Urothromboplastin evidence for similarity between urothromboplastin and human brain thromboplastin. (1983) (0)
THROMBIN INDUCED MAST CELL CHEMOTAXIS MIGHT PLAY AN ESSENTIAL ROLE IN THROMBOSIS (1999) (0)
[Clinical aspects and therapy of consumption coagulopathy]. (1971) (0)
an international working group immune thrombocytopenic purpura of adults and children: report from Standardization of terminology, definitions and outcome criteria in (2009) (0)
[Supportive therapy with thrombocyte concentrates in bone marrow transplant patients]. (1987) (0)
[Blood coagulation disorders in acute liver failure and substitution therapy (proceedings)]. (1976) (0)
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma (1984) (0)
[Acute hemolysis in polycythemia vera]. (1979) (0)
recombinant human interleukin-6 on thrombopoiesis in primates In vivo synergism of recombinant human interleukin-3 and (2011) (0)
79 Antigenic characterization of bone marrow endosteal cells: A stem cell hypothesis reevaluated (1997) (0)
General Classification System for Hemorrhagic and Thrombotic Disorders (1976) (0)
Neopterin Levels in Serum After Bone Marrow Transplantation are Possibly Helpful to Estimate the Activity of Graft-Versus-Host-Disease (1985) (0)
[Postoperative blood coagulation disorders after heart surgery when using extracorporeal circulation]. (1969) (0)
myeloid leukemia Drug treatment is superior to allografting as first-line therapy in chronic (2013) (0)
10. Infections Viral (2002) (0)
Generation of Leukemia-Derived Dendritic Cells from Patients with AML (2001) (0)
Diagnosis of carriers of haemophilia A by RFLP analysis: Austrian results. (1990) (0)
[Experiences with Rheomacrodex in the treatment of arterial circulation disorders]. (1966) (0)
Philadelphia chromosome and bcr abl rearrangement following bone marrow transplantation of ph positive cml (1990) (0)
[Right heart failure as a clinical sign of pulmonary artery sarcoma]. (1987) (0)
Subject Index, Vol. 76, 1986 (1986) (0)
PBPC mobilization with chemotherapy and G–CSF in patients with chronic myeloid leukemia: quantification of bcr/abl‐positive cells by interphase fluorescence in situ hybridization and competitive PCR (2001) (0)
[Diagnosis and therapy of consumption coagulopathy]. (1973) (0)
[Successful surgery in a patient with inhibitor substance hemophilia]. (1969) (0)
[Comparison of various methods for the testing of thrombocyte adhesiveness]. (1973) (0)
Improvement of Severe Aplastic Anemia (SAA) Following Treatment with Cyclosporin-A (CY-A) After Failure of Antithymocyte Globulin (ATG) and High-Dose Methylprednisolone (MP) (1985) (0)
Formation In Vivo Large Amounts of Vascular Endothelial Growth Factor at the Site of Hemostatic Plug (1999) (0)
[On the so-called "Reiter strain" of Spirochaeta pallida, its history, isolation, cultivation, specificity and utilization possibilities]. (1960) (0)
[Therapy of consumption coagulopathies in malignant diseases (carcinoma and leukemia)]. (1972) (0)
[Use of the cell-separator in the treatment of factor-VIII-inhibitor hemophilia]. (1976) (0)
[Control of the iproniazid effect on the catecholamines and 5-hydroxytryptamine in the rat brain by chlorpromazine]. (1961) (0)
[Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)]. (1976) (0)
Lupus anticoagulant (LAC), anticardiolipin antibodies (ACA) and thrombosis (1990) (0)
Effect of in vivo Administration of FeibaR on Clotting Tests: Dose-Response Relationship (1979) (0)
[Glutathione reductase and thriosephosphate isomerase deficiency in erythrocytes and thrombocytes in pancytopenia (Estren-Damashek type)]. (1968) (0)
[Rational substitution therapy in blood coagulation disorders]. (1980) (0)
Impact of Factor V Leiden Mutation on Duration of Anticoagulation after a Single Thromboembolic Event (1997) (0)
Contents, Vol. 76, 1986 (1986) (0)
ACQUIRED FACTOR X DEFICIENCY IN MULTIPLE MYELOMA:A COMPLETE RESPONSE TO CHEMOTHERAPY. (1987) (0)
[The Thrombosis Service in Vienna (1962-1964)]. (1966) (0)
Book reviews (2004) (0)
blood transfusions Lymphokine overproduction in severe aplastic anemia is not related to (2011) (0)
Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of (2013) (0)
Ghronic Renal Failure (2018) (0)
Clinical Features of VTE and Risk Factors for Thrombosis in the Patient Group (2001) (0)
ALLOGENIC TRANSPLANTATION REPORTS AND ANALYSIS OF RESULTS PRESENTED BY CENTRAL EUROPEAN BMT UNITS : EXPERIENCE WITH ALLOGENEIC AND SYNGENEIC BLOOD STE M CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (1998) (0)
[Early diagnosis of thrombosis susceptibility (proceedings)]. (1976) (0)
QuantitationofMinimal Residual Disease in AcuteMyeloid Leukemia by TryptaseMonitoring Identifies a Group of Patientswith a High Riskof Relapse (2005) (0)
The risk of recurrent venous thromboembolic disease-implications for treatment (2000) (0)
Interleukin-4 Downregulates Expression of c-kit mRNA and YB5.B8 Antigen (Stem Cell Factor Receptor) in Human Myeloid/Mast Cell Progenitor Cells (1992) (0)
[Interferon therapy in hematologic neoplasms]. (1988) (0)
Primary Autoimmune Warm Antibody Hemolytic Anemias (2016) (0)
[A 61-year-old male with a high-grade duodenal stenosis]. (1986) (0)
P5367Chronic inflammation after splenectomy is a risk factor for increased thrombotic cardiovascular events (2017) (0)
Book Reviews (1869) (0)
[Recent developments in the field of fibrinolytics and anticoagulants]. (1984) (0)
[Immunological determination of blood coagulation factors and their importance in the liver diagnosis]. (1976) (0)
Phänotypische Klassifikation akuter Leukosen durch funktionelle Parameter: Implikationen für Subklassifikation und Prognose (1982) (0)
Relapse of Chronic Myelogenous Leukemia 12 Years After Allogeneic Marrow Transplantation: Successful Second Transplantation with Allogeneic Peripheral Blood Progenitor Cells (2000) (0)
[Bone marrow transplantation for aplastic anemia--initial results in 8 patients]. (1982) (0)
Effect of PEG-rHu MGDF in the induction treatment of acute myeloid leukemia (1997) (0)
[On the diagnosis and therapy of blood coagulation disorders in relation to surgical interventions in the ear-nose-throat region]. (1965) (0)
[Treatment of Waterhouse-Friderichsen syndrome using heparin]. (1969) (0)
11th Annual meeting of the EBMT (1985) (0)
acute myeloid leukemia Expression of mast cell tryptase by myeloblasts in a group of patients with (2013) (0)
ß Thromboglobulin (βTG), Platelet Factor 4 (PF4), and Fibrinopeptide A (FPA) in Patients with Porcine (PO) and Prosthetic (PR) Heart Valves (1979) (0)
The Natural History Of Hemophilic Factor VIII-Antibodies: Differences In The Half Disappearance Time Following Anamnestic Rise (1981) (0)
Failure of Cryoprecipitate to Normalize Platelet Retention in Hereditary and Acquired von Willebrand’s Disease (VWD). (1979) (0)
[Stomach resection (B.II) in hemophilia A (factor 8 deficiency)]. (1966) (0)
Novo Acute Myeloid Leukemia Expression of the Lung Resistance Protein Predicts Poor Outcome in De (2011) (0)
[The level of plasmakininogen and proteinase inhibitors; studies during the substitution therapy in hemophilia A]. (1967) (0)
[A 51-year-old asymptomatic female patient with a palpable tumor in the left upper abdomen]. (1982) (0)
[The disseminated intravascular coagulation (dic) from a pediatric point of view (author's transl]. (1976) (0)
Buffy Coat Collection and Incubation with a Cytotoxic Compound (ASTA Z 7557) in Patients with Previously Untreated Chronic Granulocytic Leukemia (CGL) (1985) (0)
[Fibrinolytic and anticoagulant therapy of acute deep venous thrombosis (proceedings)]. (1976) (0)
106 Mast cell (MC) lineage involvement in myelo-dysplastic syndromes: Diagnostic utility of tryptase staining (1997) (0)
[Diagnosis of thrombophilia--cui bono?]. (1996) (0)
[Synovectomy in the prevention of recurrent joint bleedings in haemophilia (author's transl)]. (1976) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Klaus Lechner?

Klaus Lechner is affiliated with the following schools: